Adjuvant Lung Cancer – Roy Herbst, MD and Robert Figlin, MD discuss the recent ASCO20 plenary presentation of the ADAURA study investigating the use of Tagrisso (osimertinib) in the adjuvant setting for NSCLC EGFR+ patients - a podcast by OBR Peer-Spectives

from 2020-06-25T15:47:52

:: ::

Roy Herbst, MD and Robert Figlin, MD discuss the implications of the recent ASCO20 presentation of the ADAURA study investigating the use of Tagrisso (osimertinib) in Stage I-III EGFR+ NSCLC patients

Further episodes of OBR Peer-Spectives

Further podcasts by OBR Peer-Spectives

Website of OBR Peer-Spectives